Transaction · 0002021233-26-000016

Foff Erin Pennock

Foff Erin Pennock, CMO, reported an open-market or private sale at MapLight Therapeutics, Inc. involving 15355.000000 shares for an estimated $124068.40. Reported holdings after the transaction were 296906.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

Open-market sellSEC transaction code SCMO
MPLTMapLight Therapeutics, Inc.
Estimated value-$124kShares × reported price
Shares traded15.3k$8.08 per share
Holdings after296kDirect
% of reported position traded4.92%This security and ownership context
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 312,261 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

MPLT price since this filing

Daily closing prices, with the filing date and available return windows
MPLT · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +56.9%1w ago +18.8%1d ago +1.4%
Returns since7d30d90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0002021233-26-000016
Voting Common Stock
Transaction date
Oct 15, 2026
Filed Oct 16, 2026, 09:00 PM · 1d delay
Shares
15,355 sh
$8.08 per share
Estimated value
-$124k
Computed from shares × price
Holdings after
296,906 sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Cluster Selling Direct Ownership
Filing-only score

+10 points

Compact filing score computed from stored Form 4 facts. Version v1.

Positive filing signal

This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.

How this score is calculated
  • direct_ownership+6 points

    direct_or_indirect_ownership = D

    Direct ownership reports the insider's personal stake.
  • timely_filing+4 points

    reporting_delay_days = 1

    Filing reported within two business days of the transaction.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

Chief Medical Officer

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the Issuer…

  2. F2

    The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.755 to $8.3732 inclusive. The Reporting Person undertakes to provi…

Original filing · 0002021233-26-000016
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

MPLT